Method for diagnosing malignant tumors

Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals – Carrier is organic

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

436543, 436805, 436811, 436813, 436824, G01N 33544, G01N 33531

Patent

active

048409154

ABSTRACT:
This invention is directed to a novel group of compounds, herein termed Recognins. Recognins are made by treating malignant tumor cells or artificial cancer cells and separating the desired products. The Recognins may be used to prepare their Chemoreciprocals, i.e., by contacting the Recognins or the Recognins on a support with body fluids. These Chemoreciprocals are useful for diagnostic and therapeutic purposes, i.e., for diagnosing and treating cancers. The Chemoreciprocals are substances which react with immunochemical-like specificity with a Recognin in vivo or in vitro, e.g., in a quantitative precipitin test, in Ouchterlony double diffusion or in immunofluorescence.

REFERENCES:
patent: 4196186 (1980-04-01), Bogoch

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for diagnosing malignant tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for diagnosing malignant tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing malignant tumors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-525295

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.